Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-009-1259-xPMID 19727712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parkinsonism and Related Disorders

  2011cited by this paper
• Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease

  2008cited by this paper
• Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson’s disease patients

  2008influential reference
• The basal ganglia: an overview of circuits and function.

  2008cited by this paper
• The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

  2008cited by this paper
• A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements

  2007influential reference
• Changes in network activity with the progression of Parkinson's disease.

  2007cited by this paper
• Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease

  2007influential reference
• Assessment of the progression of Parkinson's disease: a metabolic network approach.

  2007cited by this paper
• [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset

  2007cited by this paper
• Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study.

  2007cited by this paper
• Impact of chronic subthalamic high‐frequency stimulation on metabolic basal ganglia activity: a 2‐deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease

  2007cited by this paper
• Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

  2007cited by this paper
• Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease

  2006cited by this paper
• Reciprocal Benefits of Mass-Univariate and Multivariate Modeling in Brain Mapping: Applications to Event-Related Functional MRI, H2 15O-, and FDG-PET

  2006cited by this paper
• Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases

  2006cited by this paper
• Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease

  2006influential reference
• FDG PET in the differential diagnosis of parkinsonian disorders

  2005cited by this paper
• How does Parkinson's disease begin? The role of compensatory mechanisms.

  2004cited by this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004influential reference
• Levodopa and the progression of Parkinson's disease.

  2004cited by this paper
• Executive processes in Parkinson's disease: FDG‐PET and network analysis

  2004cited by this paper
• Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.

  2003cited by this paper
• Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model

  2003cited by this paper
• Role of dopamine transporter imaging in routine clinical practice

  2003cited by this paper
• Imaging studies in movement disorders.

  2003cited by this paper
• Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)

  2002cited by this paper
• Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography

  2002cited by this paper
• The Metabolic Substrates of Bradykinesia and Tremor in Uncomplicated Parkinson's Disease

  2002cited by this paper
• Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

  2002cited by this paper
• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

  2001cited by this paper
• Functional brain networks in Parkinson's disease.

  2001cited by this paper
• The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

  2001cited by this paper
• Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake

  2000cited by this paper
• Pathophysiology of the basal ganglia in Parkinson's disease.

  2000cited by this paper
• Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

  1998cited by this paper
• Theoretical determination of the collimator geometrical transfer function for the reconstruction of SPECT data

  1998influential reference
• Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease

  1998cited by this paper
• A unified statistical approach for determining significant signals in images of cerebral activation

  1996cited by this paper
• Accelerated image reconstruction using ordered subsets of projection data

  1994influential reference
• The Metabolic Topography of Parkinsonism

  1994cited by this paper
• Least squares algorithm for region-of-interest evaluation in emission tomography

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Least-Squares Fitting of Two 3-D Point Sets

  1987cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

  1986influential reference
• Parkinsonism

  1967cited by this paper

• Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders

  2022cites this paper
• Brain Metabolic Correlates of Dopaminergic Denervation in Prodromal and Early Parkinson's Disease

  2022cites this paper
• Parkinson’s Disease

  2021cites this paper
• Dopaminergic and Serotonergic Degeneration and Cortical [18F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease

  2021cites this paper
• Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction

  2021cites this paper
• Compartment model-based nonlinear unmixing for kinetic analysis of dynamic PET images

  2020cites this paper
• Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson’s Disease

  2020cites this paper
• Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

  2019cites this paper
• Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates.

  2019cites this paper
• Nigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial Hypometabolism.

  2019cites this paper
• Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease: A Dual-Tracer PET Study

  2018cites this paper
• Validation du logiciel de semi-quantification DaTQUANT® dans l’aide à l’analyse visuelle en TEMP au 123I-FP-CIT dans l’étude des pathologies neurodégénératives

  2017cites this paper
• Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET

  2017cites this paper
• Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease

  2017cites this paper
• Behavioural and neuroimaging correlates of impaired self-awareness of hypo- and hyperkinesia in Parkinson's disease.

  2016cites this paper
• Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study

  2016cites this paper
• Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using 18F‐FP‐CIT

  2016cites this paper
• Nuclear Medicine Applications in Movement Disorders

  2016influential citation
• Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease.

  2015cites this paper
• Dopaminergic correlates of metabolic network activity in Parkinson's disease

  2015cites this paper
• The Effects of Exercise on Dopamine Neurotransmission in Parkinson’s Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry

  2015cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• Brain 18F-FDG PET Imaging in the Differential Diagnosis of Parkinsonism

  2014cites this paper
• Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET

  2014cites this paper
• Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study

  2013cites this paper
• Assessment of Early Phase $^{18}{\rm F}$-FP-CIT PET as an Alternative Method of FDG PET for Voxel Based Statistical Analysis: Application for Parkinson's Disease Rat Model

  2013cites this paper
• Regions of Interest–Based Discriminant Analysis of DaTSCAN SPECT and FDG-PET for the Classification of Dementia

  2013cites this paper
• Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.

  2012cites this paper
• Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.

  2012cites this paper
• [Interobserver agreement in the visual and semi-quantitative analysis of the 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome].

  2011cites this paper
• Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson’s disease

  2011influential citation
• Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism

  2011cites this paper
• PET/CT in diagnosis of movement disorders

  2011cites this paper
• Is the time ripe to adopt semiquantitative analysis of SPECT evaluation in movement disorders as a standard?

  2011cites this paper
• Concordancia interobservador en el análisis visual y semicuantitativo de las imágenes SPECT 123I-FP-CIT en el diagnóstico del síndrome parkinsoniano

  2011cites this paper
• Bridging Motor Control and Biomechanics Engaging Cognitive Circuits to Promote Motor Recovery in Degenerative Disorders. Exercise as a Learning Modality the Concept of Neuroplasticity Has Its Roots in History Defining Neuroplasticity Exercise Enhances Recovery of Motor Behavior in Parkinsonian Roden

  year unknowncites this paper